Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds Post author: Post published:February 9, 2024 Post category:uncategorized The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR). You Might Also Like Link between gut dysbiosis and chronic diseases explored in new study December 5, 2023 Research links high pollen exposure to increased death rates in older adults February 11, 2025 AI innovation “Sturgeon” transforms pediatric brain tumor surgery October 16, 2023